Foto del docente

Federico Pea

Professore ordinario

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIOS-11/A Farmacologia

Direttore Scuola di Specializzazione in Farmacologia e Tossicologia clinica (D.I. 68/2015)

Direttore Scuola di Specializzazione in Farmacologia e Tossicologia clinica ad accesso laureati non medici

Pubblicazioni

Pasca, Samantha; PierGiorgio, Cojutti; Pea, Federico, The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison, «JOURNAL OF THROMBOSIS AND THROMBOLYSIS», 2022, 54, pp. 593 - 596 [articolo]Open Access

Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 27, pp. 294 - 298 [articolo]Open Access

Gatti M.; Cojutti P.G.; Campoli C.; Caramelli F.; Corvaglia L.T.; Lanari M.; Pession A.; Ramirez S.; Viale P.; Pea F., A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 755075, pp. 1 - 13 [articolo]Open Access

Bassetti M.; Giacobbe D.R.; Bruzzi P.; Barisione E.; Centanni S.; Castaldo N.; Corcione S.; De Rosa F.G.; Di Marco F.; Gori A.; Gramegna A.; Granata G.; Gratarola A.; Maraolo A.E.; Mikulska M.; Lombardi A.; Pea F.; Petrosillo N.; Radovanovic D.; Santus P.; Signori A.; Sozio E.; Tagliabue E.; Tascini C.; Vancheri C.; Vena A.; Viale P.; Blasi F., A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), «INFECTIOUS DISEASES AND THERAPY», 2021, 1, pp. 1 - 1 [replica/breve intervento]Open Access

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients, «INFECTION AND DRUG RESISTANCE», 2021, 14, pp. 2461 - 2498 [articolo]Open Access

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, na, pp. 1 - 22 [articolo]

Gatti M.; Pea F., Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 1271 - 1289 [articolo]Open Access

Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections, «ANTIBIOTICS», 2021, 10, Article number: 1311, pp. 1 - 12 [articolo]Open Access

Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6”, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 833 - 834 [articolo]

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access

Falcone M.; De Angelis B.; Pea F.; Scalise A.; Stefani S.; Tasinato R.; Zanetti O.; Dalla Paola L., Challenges in the management of chronic wound infections, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 26, pp. 140 - 147 [articolo]Open Access

Bassetti M.; Giacobbe D.R.; Bruzzi P.; Barisione E.; Centanni S.; Castaldo N.; Corcione S.; De Rosa F.G.; Di Marco F.; Gori A.; Gramegna A.; Granata G.; Gratarola A.; Maraolo A.E.; Mikulska M.; Lombardi A.; Pea F.; Petrosillo N.; Radovanovic D.; Santus P.; Signori A.; Sozio E.; Tagliabue E.; Tascini C.; Vancheri C.; Vena A.; Viale P.; Blasi F.; Bassetti M.; Giacobbe D.R.; De Rosa F.G.; Di Marco F., Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), «INFECTIOUS DISEASES AND THERAPY», 2021, na, pp. 1 - 49 [articolo]Open Access

Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [articolo]Open Access

Gatti, Milo; Pea, Federico, Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections, «CURRENT OPINION IN INFECTIOUS DISEASES», 2021, 34, pp. 737 - 747 [articolo]Open Access

Ultimi avvisi

Al momento non sono presenti avvisi.